Contra Hebraeos : requisitioni profundissime et argomenti sottilissimi

del Samuel ...

Confutazione degli errori de' Giudei intorno alla venuta del Messia

di Rabbi Samuello. Trad. dall' Arabico nel Latino, indi trasport. nella Italiana favella da Arizioberto Nalivaniano

Das Jhesus Nazarenus der ware Messias sey : derhalben die Juden auff kaynen andern warten dörffen

Rabbi Samuelis. Verdeütscht durch Wenzelslaum Linck

Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study

UNLABELLED Treatment effects over 2 years of teriparatide vs. ibandronate in postmenopausal women with osteoporosis were compared using lumbar spine bone mineral density (BMD) and trabecular bone score (TBS). Teriparatide induced larger increases in BMD and TBS compared to ibandronate, suggesting a more pronounced effect on bone microarchitecture of the bone anabolic drug. INTRODUCTION The trabecular bone score (TBS) is an index of bone microarchitecture, independent of bone mineral density (BMD), calculated from anteroposterior spine dual X-ray absorptiometry (DXA) scans. The potential role of TBS for monitoring treatment response with bone-active substances is not established. The aim of this study was to compare the effects of recombinant human 1-34 parathyroid hormone (teriparatide) and the bisphosphonate ibandronate (IBN), on lumbar spine (LS) BMD and TBS in postmenopausal women with osteoporosis. METHODS Two patient groups with matched age, body mass index (BMI), and baseline LS BMD, treated with either daily subcutaneous teriparatide (N = 65) or quarterly intravenous IBN (N = 122) during 2 years and with available LS BMD measurements at baseline and 2 years after treatment initiation were compared. RESULTS Baseline characteristics (overall mean ± SD) were similar between groups in terms of age 67.9 ± 7.4 years, body mass index 23.8 ± 3.8 kg/m(2), BMD L1-L4 0.741 ± 0.100 g/cm(2), and TBS 1.208 ± 0.100. Over 24 months, teriparatide induced a significantly larger increase in LS BMD and TBS than IBN (+7.6 % ± 6.3 vs. +2.9 % ± 3.3 and +4.3 % ± 6.6 vs. +0.3 % ± 4.1, respectively; P < 0.0001 for both). LS BMD and TBS were only weakly correlated at baseline (r (2) = 0.04) with no correlation between the changes in BMD and TBS over 24 months. CONCLUSIONS In postmenopausal women with osteoporosis, a 2-year treatment with teriparatide led to a significantly larger increase in LS BMD and TBS than IBN, suggesting that teriparatide had more pronounced effects on bone microarchitecture than IBN.

Sefer ha- Kuzari

des Jehuda Halevi, nach dem hebräischen Texte des Jehuda Ibn-Tibbon hrsg., übers. und mit einem Commentar, so wie mit einer allgemeinen Einleitung versehen von David Cassel

Ms. hebr. oct. 141 - Shaʹare tsedeḳ

Vorbesitzer: Abraham Merzbacher

Ms. hebr. oct. 154 - Sefer ha-ḳabalah

Vorbesitzer: Abraham Merzbacher

Sēfer mešal haq-qadmônî : doś šprechṭ .. fon fil mînê mešālîm ...

[Isaak Ben-Salomon Ibn-Abi-Sahula]

Sēfer mivḥar hap-penînîm

[Šelōmō Ben-Gabirol]

Sefer mivḥar ha-penimim

[Shelomoh ibn Gevirol]

Sēfer Šēveṭ Yehûdā : wol fere ṭaiṭšṭ ... wundr berlichi gšichṭniṭ di gišehn zain unzrn elṭrn in den goles ...

[Šelōmō Ibn-Wirgā]

Sēfer Šēveṭ Yehûdā : wol fer ṭaiṭšṭ ... wundr berlichi gšichnis di gišehn zain unzrn elṭrn in den goles ...

[Šelōmō Ibn-Wirgā]